ORIGINAL ARTICLE |
|
Year : 2022 | Volume
: 12
| Issue : 2 | Page : 94-98 |
|
Cyclosporiasis in immunocompetent and immunocompromised patients – A Twelve years experience from a tertiary care centre in Northern India
Ujjala Ghoshal1, Tasneem Siddiqui1, Nidhi Tejan1, Sheetal Verma2, Ankita Pandey1, Uday C Ghoshal3
1 Department of Microbiology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India 2 Department of Microbiology, King George's Medical University, Lucknow, Uttar Pradesh, India 3 Department of Gastroenterology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India
Correspondence Address:
Ujjala Ghoshal Department of Microbiology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Rae Bareli Road, Lucknow - 226 014, Uttar Pradesh India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/tp.tp_79_21
|
|
Context: Cyclosporiasis is an emerging enteric coccidian parasitic disease worldwide, caused by the parasite Cyclospora cayetanensis. There is scanty data from India, especially among immunocompetent patients.
Aims: The aim is to evaluate the occurrence of Cyclosporiasis in immunocompetent and immunocompromised patients.
Settings and Design: It is a prospective cohort study conducted from June 2006 to May 2018 at our tertiary care center.
Materials and Methods: Stool samples were collected from the 900 patients with diarrhea (both immunocompetent and immunocompromised) and 170 healthy controls to look for Cyclospora by modified Kinyoun staining.
Statistical Analysis: Mann–Whitney U test/Fisher exact test were used for statistical analysis.
Results: Oocysts of C. cayetanensis were detected in 10/900 patients and none of the healthy controls. The median age of patients was 38.5 years (10-65 years) and males (6/10) outnumbered the females in harboring the parasite. Eight patients were immunocompromised (five postrenal transplant cases and one-one patient each with HIV, non-Hodgkin's lymphoma, and juvenile polyarthritis), and two patients were immunocompetent. Cyclospora infection was more common in immunocompromised patients (8/300, 2.67%) than the immunocompetent patients (2/600, 0.33%); P < 0.001. Eight patients responded well to trimethoprim-sulfamethoxazole, one died, and one was lost to follow-up. Coinfection with Cryptosporidium spp. was seen in one patient.
Conclusion: Cyclospora causes diarrhea in both immunocompromised and immunocompetent persons. Its burden may be underestimated due to a lack of awareness and appropriate diagnostic methods. Special staining techniques are important for diagnosis as they may be missed by routine microscopy.
|
|
|
|
[FULL TEXT] [PDF]* |
|
 |
|